Xtant Medical Holdings Stock Performance

XTNT Stock  USD 0.48  0.03  5.88%   
On a scale of 0 to 100, Xtant Medical holds a performance score of 9. The firm maintains a market beta of 1.45, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Xtant Medical will likely underperform. Please check Xtant Medical's total risk alpha and the relationship between the downside variance and period momentum indicator , to make a quick decision on whether Xtant Medical's historical returns will revert.

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Xtant Medical Holdings are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Xtant Medical unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor
1:12
Dividend Date
2018-02-14
Last Split Date
2018-02-14
JavaScript chart by amCharts 3.21.1512345678910Dec2025FebMar -1001020304050
JavaScript chart by amCharts 3.21.15Xtant Medical Holdings Xtant Medical Holdings Dividend Benchmark Dow Jones Industrial
1
Disposition of 105442 shares by Sean Browne of Xtant Medical at 1.08 subject to Rule 16b-3
12/19/2024
2
Disposition of 56333 shares by Kevin Brandt of Xtant Medical at 0.6 subject to Rule 16b-3
12/27/2024
3
Three Value Stocks Estimated Below Intrinsic Worth For January 2025
01/14/2025
4
3 Stocks That May Be Trading Up To 40.9 percent Below Estimated Intrinsic Value
01/15/2025
5
Xtant Medical Stock Price Passes Above 200-Day Moving Average - Heres Why - MarketBeat
02/07/2025
6
NanoVibronix, Inc. Announces Acquisition of ENvue Medical Holdings, Corp.
02/14/2025
7
Adagio Medical to Participate at the TD Cowens 45th Annual Health Care Conference
02/18/2025
8
Asian Value Stocks Trading Below Estimated Worth In March 2025
03/05/2025
9
Xtant Medical Holdings Inc Reports Q4 EPS of 0. ...
03/06/2025
10
Q4 2024 Xtant Medical Holdings Inc Earnings Call Transcript
03/07/2025
Begin Period Cash Flow5.9 M
  

Xtant Medical Relative Risk vs. Return Landscape

If you would invest  35.00  in Xtant Medical Holdings on December 16, 2024 and sell it today you would earn a total of  13.00  from holding Xtant Medical Holdings or generate 37.14% return on investment over 90 days. Xtant Medical Holdings is currently generating 0.684% in daily expected returns and assumes 5.8502% risk (volatility on return distribution) over the 90 days horizon. In different words, 52% of stocks are less volatile than Xtant, and 87% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
JavaScript chart by amCharts 3.21.15CashMarketXTNT 0123456 -0.10.00.10.20.30.40.50.60.7
       Risk  
Given the investment horizon of 90 days Xtant Medical is expected to generate 6.53 times more return on investment than the market. However, the company is 6.53 times more volatile than its market benchmark. It trades about 0.12 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly -0.09 per unit of risk.

Xtant Medical Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Xtant Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Xtant Medical Holdings, and traders can use it to determine the average amount a Xtant Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.1169

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsXTNT
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 5.85
  actual daily
52
52% of assets are less volatile

Expected Return

 0.68
  actual daily
13
87% of assets have higher returns

Risk-Adjusted Return

 0.12
  actual daily
9
91% of assets perform better
Based on monthly moving average Xtant Medical is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Xtant Medical by adding it to a well-diversified portfolio.

Xtant Medical Fundamentals Growth

Xtant Stock prices reflect investors' perceptions of the future prospects and financial health of Xtant Medical, and Xtant Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Xtant Stock performance.
Return On Equity-0.35
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-300%-250%-200%-150%-100%-50%0%
Return On Asset-0.081
Profit Margin(0.14) %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%500%1,000%1,500%2,000%2,500%
Operating Margin(0.06) %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%500%1,000%1,500%2,000%
Current Valuation99.87 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-60%-40%-20%0%
Shares Outstanding139.07 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3110,000%20,000%30,000%40,000%50,000%
Price To Earning(0.41) X
Price To Book1.65 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-100%-80%-60%-40%-20%
Price To Sales0.57 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-100%-80%-60%-40%-20%
Revenue117.27 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-315,000%10,000%15,000%20,000%25,000%
Gross Profit68.22 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3120,000%40,000%60,000%80,000%
EBITDA(12.07 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-40,000%-20,000%0%20,000%40,000%60,000%80,000%
Net Income(16.45 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%100,000%200,000%300,000%400,000%
Cash And Equivalents16.5 M
Cash Per Share0.19 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%1,000%2,000%3,000%4,000%5,000%6,000%7,000%
Total Debt12.94 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31500%1,000%1,500%2,000%2,500%3,000%3,500%
Debt To Equity0.60 %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-2,000%-1,000%0%1,000%
Current Ratio3.57 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3150%100%150%200%250%
Book Value Per Share0.31 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-80,000%-60,000%-40,000%-20,000%0%20,000%40,000%
Cash Flow From Operations(11.9 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-30,000%-20,000%-10,000%0%
Earnings Per Share(0.12) X
Market Capitalization66.75 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-100%-80%-60%-40%-20%0%
Total Asset93.84 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3120,000%40,000%60,000%80,000%100,000%
Retained Earnings(259.46 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31500,000%1,000,000%1,500,000%2,000,000%2,500,000%3,000,000%
Working Capital38.53 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Current Asset45.04 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3110,000%20,000%30,000%40,000%
Current Liabilities21.47 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-315,000%10,000%15,000%20,000%25,000%

About Xtant Medical Performance

Assessing Xtant Medical's fundamental ratios provides investors with valuable insights into Xtant Medical's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Xtant Medical is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 287.48  378.37 
Return On Tangible Assets(0.21)(0.22)
Return On Capital Employed(0.19)(0.19)
Return On Assets(0.18)(0.18)
Return On Equity(0.38)(0.36)

Things to note about Xtant Medical Holdings performance evaluation

Checking the ongoing alerts about Xtant Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Xtant Medical Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Xtant Medical is way too risky over 90 days horizon
Xtant Medical has some characteristics of a very speculative penny stock
Xtant Medical appears to be risky and price may revert if volatility continues
The company reported the previous year's revenue of 117.27 M. Net Loss for the year was (16.45 M) with profit before overhead, payroll, taxes, and interest of 68.22 M.
Xtant Medical Holdings currently holds about 16.5 M in cash with (11.9 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.19.
Xtant Medical has a frail financial position based on the latest SEC disclosures
Roughly 70.0% of the company outstanding shares are owned by institutional investors
Latest headline from gurufocus.com: Q4 2024 Xtant Medical Holdings Inc Earnings Call Transcript
Evaluating Xtant Medical's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Xtant Medical's stock performance include:
  • Analyzing Xtant Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Xtant Medical's stock is overvalued or undervalued compared to its peers.
  • Examining Xtant Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Xtant Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Xtant Medical's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Xtant Medical's stock. These opinions can provide insight into Xtant Medical's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Xtant Medical's stock performance is not an exact science, and many factors can impact Xtant Medical's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Additional Tools for Xtant Stock Analysis

When running Xtant Medical's price analysis, check to measure Xtant Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xtant Medical is operating at the current time. Most of Xtant Medical's value examination focuses on studying past and present price action to predict the probability of Xtant Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xtant Medical's price. Additionally, you may evaluate how the addition of Xtant Medical to your portfolios can decrease your overall portfolio volatility.